A model of Salmonella colitis with features of diarrhea in SLC11A1 wild-type mice

PLoS ONE

Volumn 3, Issue 2, 2008, Pages

  Woo, Heungjeong ^a,d   Okamoto, Sharon ^a   Guiney, Donald ^b   Gunn, John S ^c   Fierer, Joshua ^a,b  

^a Veterans Affairs ^*  (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d Hankang Sacred Heart Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 91; KANAMYCIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; NITRATE REDUCTASE (NADPH); CATION TRANSPORT PROTEIN; CYBB PROTEIN, MOUSE; MEMBRANE PROTEIN; NATURAL RESISTANCE-ASSOCIATED MACROPHAGE PROTEIN 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; BAGG ALBINO MOUSE; CECUM; COLITIS; COLON; CONGENIC STRAIN; CONTROLLED STUDY; DIARRHEA; DISEASE MODEL; FECES ANALYSIS; HOST RESISTANCE; MOUSE; MUTANT; NONHUMAN; PATHOGENESIS; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SCORING SYSTEM; STRAIN DIFFERENCE; VISUAL SCORING SYSTEM; WATER CONTENT; WEIGHT REDUCTION; WILD TYPE; ANIMAL; ANIMAL SALMONELLOSIS; DISEASE PREDISPOSITION; GENETICS; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY;

MUS; SALMONELLA; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM;

ANIMALS; CATION TRANSPORT PROTEINS; COLITIS; COLON; DIARRHEA; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; KANAMYCIN; MEMBRANE GLYCOPROTEINS; MICE; NADPH OXIDASE; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM;

EID: 45449087568     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001603     Document Type: Article

References (54)

1. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, et al. (1999) Food-related illness and death in the United States. Emerg Inf Dis 5: 607-624.
2. Roberts T (1989) Human illness costs of foodborne bacteria. Am J Agricultural Econ 71: 468-474.
3. Helms M, Ethelberg S, Molbak K, DT104 Study Group (2005) International Salmonella Typhimurium DT104 Infections, 1992-2001. Emerg Inf Dis 11: 859-867.
4. Varma JK, Greene KD, Ovitt J, Barrett TJ, Medalla F, et al. (2005) Hospitalization and antimicrobial resistance in Salmonella outbreaks,1984-2002. Emerg Inf Dis 11: 943-946.
5. Jones BD, Paterson HF, Hall A, Falkow S (1993) Salmonella typhimurium induces membrane ruffing by a growth factor-receptor-independent mechanism. Proc Natl Acad Sci U S A 90: 10390-10394.
6. Galan JE, Curtiss R III (1989) Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells. Proc Natl Acad Sci U S A 86: 6383-6387.
7. Schlumberger MC, Hardt W-D (2006) Salmonella type III secretion effectors: pulling the host cell's strings. Curr Opin Microbiol 9: 46-54.
8. Eckmann L, Kagnoff MF, Fierer J (1993) Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immun 61: 4569-4574.
9. Elewaut D, DiDonato JA, Kim JM, Truong F, Eckmann L, et al. (1999) NF-κB is a central regulator of the intestinal epithelial bell innate immune response induced by infection with enteroinvasive bacteria. J Immunol 163: 1457-1466.
10. Tsolis RM, Adams LG, Ficht TA, Bäumler AJ (1999) Contribution of Salmonella typhimurium virulence factors to diarrheal disease in calves. Infect Immun 67: 4879-4885.
11. Bertelsen LS, Paesold G, Marcus SL, Finlay BB, Eckmann L, et al. (2004) Modulation of chloride secretory responses and barrier function of intestinal epithelial cells by the Salmonella effector protein SigD. Am J Physiol Cell Physiol 287: C939-C948.
12. Bohnhoff M, Drake BL, Miller CP (1954) Effect of streptomycin on susceptibility of intestinal tract to experimental Salmonella infection. Proc Soc Exp Biol Med 86: 132-137.
13. Ruitenberg EJ, Guince PAM, Kruyt BC, Berkvens JM (1971) Salmonella pathogenesis in germ-free mice. A bacteriological and histologic study. Br J Exp Path 52: 192-197.
14. Barthel M, Hapfelmeier S, Quintanilla-Martinez L, Kremer M, Rohde M, et al. (2003) Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun 71: 2839-2858.
15. Hapfelmeier S, Ehrbar K, Stecher B, Barthel M, Kremer M, et al. (2004) Role of the Salmonella pathogenicity island 1 effector proteins SipA, SopB, SopE, and SopE2 in Salmonella enterica subspecies 1 serovar Typhimurium colitis in streptomycin-pretreated mice. Infect Immun 72: 795-809.
16. Coburn B, Li Y, Owen D, Vallance BA, Finlay BB (2005) Salmonella enterica Serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitis. Infect Immun 73: 3219-3227.
17. Vidal SK Malo D, Vogan K, Skamene E, Gros P (1993) Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 73: 469-485.
18. Galan JE (1992) Molecular and functional characterization of the Salmonella invasion gene invA: homology of InvA to members of a new protein family. J Bacteriol 174: 4338-4349.
19. Valle E, Guiney DG (2005) Characterization of Salmonella-induced cell death in human macrophage-like THP-1 cells. Infect Immun 73: 2835-2840.
20. Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, et al. (2000) Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine 79: 155-169.
21. Dinauer MG, Deck MB, Unanue ER (1997) Mice lacking reduced nicotinamide adenine dinucleotide phosphate oxidase activity show increased susceptibility to early infection with Listeria monocytogenes. J Immunol 158: 5581-5583.
22. Foster N, Hulme SD, Barrow PA (2006) Vasoactive intestinal peptide (VIP) prevents killing of virulent and phoP mutant Salmonella typhimurium by inhibiting IFN-γ stimulated NADPH oxidative pathways in murine macrophages. Cytokine 36: 134-140.
23. Nakao M, Ogura Y, Satake S, Ito I, Iguchi A, et al. (2002) Usefulness of soluble dietary fiber for the treatment of diarrhea during enteral nutrition in elderly patients. Nutrition 18: 35-39.
24. Nishimuta M, Inoue N, Kodama N, Morikuni E, Yoshioka YH, Matsuzaki N, Shimada M, Sato N, Iwamoto T, Ohki K, Takeyama H, Nishimuta H (2006) Moisture and mineral content of human feces - high fecal moisture is associated with increased sodium and decreased potassium content -. J Nutr Sci Vitaminol 52: 121-126.
25. Guttman JA, Li Y, Wickham ME, Deng W, Vogi AW, et al. (2006) Attaching and effacing pathogen-induced tight junction disruption in vivo. Cell Microbiol 8: 634-645.
26. Kunzehnan K, Mall M (2002) Electrolyte transport in the mammalian colon: mechanisms and implications for disease. Physiol Rev 82: 245-280.
27. Hapfelmeier S, Stecher B, Barthel M, Kremer M, Miller AJ, et al. (2005) The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar Typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms. J Immunol 174: 1675-1685.
28. +/+ mice. Infect Immun 74: 5047-5057.
29. Garg P, Rojas M, Ravi A, Bockbradet K, Epstein S, et al. (2006) Selective ablation of matrix metalloproteinase-2 exacerbates experimental colitis: contrasting role of gelatinases in the pathogenesis of colitis. J Immunol 177: 4103-4112.
30. Galan JE, Collmer A (1999) Type III secretion machines: bacterial devices for protein delivery into host cells. Science 284: 1322-1328.
31. Rollenhagen C, Bumann D (2006) Salmonella enterica highly expressed genes are disease specific. Infect Immun 74: 1649-1660.
32. Vazquez-Torres A, Jones-Carson J, Baumler AJ, Falkow S, Valdivia R, et al. (1999) Extra-intestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature 401: 804-808.
33. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S (1999) Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122.
34. Coombes BK, Coburn BA, Potter AA, Gomis S, Mirakhur K, et al. (2005) Analysis of the contribution of Salmonella pathogenicity islands 1 and 2 to enteric disease progression using a novel bovine ileal loop model and a murine model of infectious enterocolitis. Infect Immun 73: 7161-7169.
35. Jung HC, Eckmann L, Yang S-K, Panja A, Fierer J, et al. (1995) A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 95: 55-65.
36. + lamina propria cells. Nature Immunol 7: 868-874.
37. Miller SI, Kukral AM, Mekalanos JJ (1989) A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc Natl Acad Sci U S A 86: 5054-5058.
38. Ernst RK, Guina T, Miller SI (2001) Salmonella typhimurium outer membrane remodeling: role in resistance to host innate immunity. Microbes Infect 3: 1327-1334.
39. Behlau I, Miller SI (1993) A PhoP-repressed gene promotes Salmonella typhimurium invasion of epithelial cells. J Bacteriol 175: 4475-4484.
40. Kato A, Groismart EA (2004) Connecting two-component regulatory systems by a protein that protects a response regulator from dephosphorylation by its cognate sensor Genes and Development 18: 2302-2313.
41. Gunn JS, Miller SI (1996) PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance. J Bacteriol 178: 6857-6864.
42. Shi Y, Cromin MJ, Hsu F-F, Turk J, Groisman EA (2004) PhoP-regulated Salmonella resistance to the antimicrobial peptides magainin 2 and polymyxin B. Mol Microbiol 53: 229-241.
43. Shiloh MU, MacMicking JD, Nicholson S, Brause JE, Potter S, et al. (1999) Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity 10: 29-38.
44. Roy M-F, Malo D (2002) Genetic regulation of host responses to Salmonella infection in mice. Genes and Immun 3: 381-393.
45. McGovern VJ, Slavutin LJ (1979) Pathology of salmonella colitis. Am J Surg Pathol 3: 483-490.
46. Day DW, Mandal BK, Morson BC (1976) The rectal biopsy appearances in Salmonella colitis. Histopathology 2: 117-131.
47. Chao H-C, Chiu C-H, Kong M-S, Chang L-Y, Huang Y-C, et al. (2000) Factors associated with intestinal perforation in children's non-typhi Salmonella toxic megacolon. Pediatr Infect Dis 19: 1158-1162.
48. Gly169 allele. Infect Immun 64: 2923-2929.
49. Potter M, O'Brien AD, Skamene E, Gros P, Forget A, et al. (1983) A BALB/ c congenic strain of mice that carries a genetic locus (Ity) controlling resistance to intracellular parasites. Infect Immun 40: 1234-1235.
50. Heffernan EJ, Fierer J, Chikami G (1987) Guiney D. Natural history of oral Salmonella dublin infection in BALB/c mice: effect of an 80-kilobase-pair plasmid on virulence. J Infect Dis 155: 1254-1259.
51. Lesnick ML, Reiner NE, Fierer J, Guiney DG (2001) The Salmonella spvB virulence gene encodes an enzyme that ADP-ribosylates actin and destabilizes the cytoskeleton of eukaryotic cells. Mol Microbiol 39: 1464-1470.
52. Browne SH, Lesnick ML, Guiney DG (2002) Genetic requirements for Salmonella-induced cytopathology in human monocyte-derived macrophages. Infect Immun 70: 7126-7135.
53. Gunn JS, Lim KB, Krueger J, Kim K, Guo L, et al. (1998) PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mot Microbiol 27: 1171-1182.
54. Vassiloyanakopoulos AP, Okamoto S, Fierce J (1998) The crucial role of polymophonuclear leukocytes in resistance to Salmonella dublin infections in genetically susceptible and resistant mice. PNAS 95: 7676-7681.